Short vs Long Duration Dual Antiplatelet Therapy in Patients Undergoing Lower Extremity Endovascular Revascularization
Status:
Withdrawn
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of the trial is to evaluate short versus long duration dual
antiplatelet therapy in patients undergoing lower extremity endovascular revascularization.